Purity, ID & Quantitation
View the analytical report assigned to this product option.
View COA↗Imagine First
CJC-1295/IPAMORELIN
CJC-1295/IPAMORELIN
Regular price
$89.00
Regular price
Sale price
$89.00
Shipping calculated at checkout.
Quantity
Couldn't load pickup availability
CJC-1295/IPAMORELIN is a dual-peptide research blend studied in controlled laboratory models involving GHRH, ghrelin-receptor, and growth-hormone signaling pathways. Supplied as a clearly labeled 10 mg lyophilized research material.
Order individual vials. Lab Mix savings apply automatically in your cart as you add eligible vials. Variant-specific analytical documentation can be viewed through the COA section when available.
For laboratory research use only.
Documentation
Certificate of Analysis
Select a product option to view its available documentation.
Endotoxin
View the endotoxin report assigned to this product option.
View COA↗Documentation applies only to the product option and lot identified in each report.
Research overview
Two signaling approaches in one research blend.
CJC-1295 is studied as an analog of growth-hormone-releasing hormone, while Ipamorelin is studied as a selective agonist of the growth-hormone-secretagogue receptor. Blend-specific conclusions require direct experimental validation.
GHRHCJC-1295 research centers on signaling through the GHRH receptor pathway.
GHSRIpamorelin is characterized as a ghrelin-receptor or GHSR agonist.
BlendComponent identity and ratio should be confirmed in the current lot report.
PresentationTwo-component blend
Ipamorelin formulaC38H49N9O5
Ipamorelin mass711.9 g/mol
Material formLyophilized powder
Compound Profile & Technical Overview
This 10MG research presentation combines CJC-1295 and Ipamorelin. CJC-1295 is described in published literature as a synthetic analog of growth-hormone-releasing hormone. Ipamorelin is a pentapeptide growth-hormone secretagogue investigated as an agonist at the ghrelin or GHSR1a receptor; PubChem reports its formula as C38H49N9O5 and molecular weight as 711.9 g/mol. Because CJC-1295 naming can refer to different molecular forms, the current lot's Purity, ID & Quantitation report should be treated as the controlling source for exact component identity, ratio, and measured content. Research on either component alone does not establish the behavior of the combined material.
Storage requirements
Protect from lightKeep refrigerated after reconstitutionAvoid freeze/thaw cycles
Lyophilized powder-20°CStated stability: 24+ months
Reconstituted solution2-8°CStated stability: approximately 30 days
Sealed lyophilized vials are described as heat-stable; refrigeration or freezing of sealed vials is optional. The 2-8°C guidance applies after reconstitution. Always follow the lot-specific documentation when it differs.
Published Research & References
Research resources: randomized CJC-1295 pharmacology study, CJC-1295 pulsatility research, Ipamorelin pharmacological characterization, and PubChem Ipamorelin profile. These component-level sources do not establish safety, efficacy, or expected outcomes for this research blend.
Important research notice
This material is offered strictly for laboratory research use. It is not intended for human or veterinary use, food use, compounding, diagnosis, treatment, cure, or prevention of disease. Published findings are provided only as educational research context and do not establish equivalence to this independently supplied blend.
FOR LABORATORY RESEARCH USE ONLY · NOT FOR HUMAN OR VETERINARY USE · NOT A DRUG, FOOD, COSMETIC, OR MEDICAL PRODUCT